Literature DB >> 18449171

Activation of Erk1/2 and Akt following unilateral ureteral obstruction.

Ana B Rodríguez-Peña1, Maria T Grande, Nélida Eleno, Miguel Arévalo, Carmen Guerrero, Eugerio Santos, José M López-Novoa.   

Abstract

Chronic unilateral ureteral obstruction is a well characterized model of renal injury leading to tubulointerstitial fibrosis and distinct patterns of cell proliferation and apoptosis in the obstructed kidney. In this study we assessed the contribution of the mitogen activated protein kinase (MAPK)-ERK1/2 and the phosphatidylinositol 3 kinase (PI3K)-Akt pathways to early renal changes following unilateral obstruction. Increased activation of small Ras GTPase and its downstream effectors ERK1/2 and Akt was detected in ligated kidneys. The use of specific pharmacological inhibitors to either ERK1/2 or Akt activation led to decreased levels of fibroblast-myofibroblast markers in the interstitium while inhibition of PI3K reduced the number of proliferating cells and the amount of interstitial extracellular matrix deposition. Treatment with an ERK1/2 inhibitor diminished the number of apoptotic tubule and interstitial cells. Our results suggest a role for the MAPK-ERK1/2 and PI3K-Akt systems in early changes induced by ureteral obstruction and that inhibition of these signaling pathways may provide a novel approach to prevent progression of renal fibrosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18449171     DOI: 10.1038/ki.2008.160

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  34 in total

1.  The MEK Inhibitor Trametinib Ameliorates Kidney Fibrosis by Suppressing ERK1/2 and mTORC1 Signaling.

Authors:  Petros Andrikopoulos; Julius Kieswich; Sabrina Pacheco; Luxme Nadarajah; Steven Michael Harwood; Caroline E O'Riordan; Christoph Thiemermann; Muhammad M Yaqoob
Journal:  J Am Soc Nephrol       Date:  2018-12-10       Impact factor: 10.121

2.  Suramin inhibits renal fibrosis in chronic kidney disease.

Authors:  Na Liu; Evelyn Tolbert; Maoyin Pang; Murugavel Ponnusamy; Haidong Yan; Shougang Zhuang
Journal:  J Am Soc Nephrol       Date:  2011-05-26       Impact factor: 10.121

3.  Hedgehog-Gli pathway activation during kidney fibrosis.

Authors:  Steven L Fabian; Radostin R Penchev; Benoit St-Jacques; Anjali N Rao; Petra Sipilä; Kip A West; Andrew P McMahon; Benjamin D Humphreys
Journal:  Am J Pathol       Date:  2012-02-17       Impact factor: 4.307

Review 4.  The functional role of reactive stroma in benign prostatic hyperplasia.

Authors:  Isaiah G Schauer; David R Rowley
Journal:  Differentiation       Date:  2011-06-12       Impact factor: 3.880

5.  ErbB4 deletion accelerates renal fibrosis following renal injury.

Authors:  Fenghua Zeng; Tomoki Miyazawa; Lance A Kloepfer; Raymond C Harris
Journal:  Am J Physiol Renal Physiol       Date:  2017-07-19

6.  Role of inflammation in túbulo-interstitial damage associated to obstructive nephropathy.

Authors:  María T Grande; Fernando Pérez-Barriocanal; José M López-Novoa
Journal:  J Inflamm (Lond)       Date:  2010-04-22       Impact factor: 4.981

7.  Targeted genomic disruption of H-ras and N-ras has no effect on early renal changes after unilateral ureteral ligation.

Authors:  María T Grande; Miguel Arévalo; Alejandro Núñez; Jorge B Cannata-Andía; Eugenio Santos; José M López-Novoa
Journal:  World J Urol       Date:  2009-12       Impact factor: 4.226

8.  NAD(P)H oxidase mediates TGF-beta1-induced activation of kidney myofibroblasts.

Authors:  Corry D Bondi; Nagaraj Manickam; Duck Yoon Lee; Karen Block; Yves Gorin; Hanna E Abboud; Jeffrey L Barnes
Journal:  J Am Soc Nephrol       Date:  2009-11-19       Impact factor: 10.121

Review 9.  Fibroblast activation and myofibroblast generation in obstructive nephropathy.

Authors:  María T Grande; José M López-Novoa
Journal:  Nat Rev Nephrol       Date:  2009-06       Impact factor: 28.314

10.  Fell-Muir lecture: Connective tissue growth factor (CCN2) -- a pernicious and pleiotropic player in the development of kidney fibrosis.

Authors:  Roger M Mason
Journal:  Int J Exp Pathol       Date:  2012-10-30       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.